HAX-1 overexpression in multiple myeloma is associated with poor survival

Br J Haematol. 2019 Apr;185(1):179-183. doi: 10.1111/bjh.15430. Epub 2018 Jun 19.

Xiaoli Feng¹, Anna Kwiecinska^{2

3}, Eva Rossmann², Matteo Bottai⁴, Taichi Ishikawa⁵, Manuel Patarroyo⁵, Anders Österborg², Anna Porwit^{2

3}, Chengyun Zheng^{6

7}, Bengt Fadeel¹

¹ Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
² Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
³ Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
⁴ Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
⁵ Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
⁶ Department of Haematology, Second Hospital, Shandong University, Jinan, China.
⁷ Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.

No abstract available

Keywords: HAX-1; apoptosis; migration; multiple myeloma; survival.

Publication types